Document Page: First | Prev | Next | All | Image | This Release | Search

                                       I~.~ o%I~  110 3S'7O

                                    UNCLASSIFIED
     PRIORITY              *                    ri ~ T           *  TOD = 041 181.1


   F            (1)(u)~   DETECTION TE~MS OPER~TING TN ~ FIXED-SITE' MODE
     ~T ~IRB~SES WILL PROVIDE SUSPECT S~MPLE    (FILTER) TO THE COLLOC~TED
     ~IR TR~NSPORT~BLE HOSPIT~L L~B.   S~MPLES TH~T ~RE POSITIVE BY THIS
     SCREENING PROCESS WILL BE FORW~RDED TO ~ T~ML FOR CONFIRM~TION
     THE CENT~F PROJECT OFFICER FOR THIS DETECTION C~P~BILITY WILL
     COORDIN~T£ S~MPLE TR~NSFER PROCEDURES WITH THE T~MLS.
                (2) (U)~) DETECTION TE~MS FROM THE 9TH CHEMIC~L CO   (-)
     WILL P1ERIODIC~LLY MONITOR ~T THEIR DESIGN~TED SITES ~ND iNYESTI6~TE

"ii  SUSPECT BW ~TT~CKS ~S DIRECTED BY THE Sr.. .~ FOREir~N N~TERIEL


     P~6E c)5 RHIP~~~2~97 St E C r~ Ei T
     INTELLIGENCE B~TT~LION    NEG~TIVE S~MPLES RESULTING FROM ROUTINE
     MONITORING WILL BE HELD (REFRIGER~TED) FOR TWELVE HOURS ~ND THEN
   F DISC~RDED UNLESS OTHERWISE DIRECTED.     POSITIVE S~MPLES WILL BE
     FORW~RDED TO THE SUPPORTING (32/TECH INTELL SECTION FOR IMMEDI'~TE
     ~N~LYSIS ~T THE NE~REST T~ML.    THE T~ML WILL SPLIT THE S~MPLE UPON
     RECEIPT TO ~LLOW THE TECH INTELL TE~M TO TR~NSFER THE SPLIT TO THE
     JCMEC.
           E. (U)~)   THERE WILL BE C~SES WHERE NEG~TIVE S~MPLES (WITH THE
     FIELD TESTS) WILL BE FORW~RDED TO THE T~MLS FOR ~N~LYSIS.     IF THERE
     ~RE SUFFICIENT INDIC~TORS TO SUPPORT ~ POSSIBLE BW ~TT~Ci::, ~
     COMPREHENSIVE L~BOR~TORY 4SSESSMENT WILL BE CONDUCTED REG~RDLESS OF
     THE PRELIMIN~RY FIELD TEST'S NEG~TIVE RESULT      IN THESE C~SES THE
     TR~NSFER TO THE T4ML WILL BE DIRECTED BY CENTCOM Jr..
           (U)  BIOMEDiC~L S~MPLES
           ~. (U) ~D) UNITS RESPONSIBLE FOR BIOMEDIC~L S~MPLES ~RE B~TT~LION
     LEVEL MEDIC~L UNITS~ DIVISION LEVEL MEDIC~L TRE~TMENT F~CILITIES
      (MTF), MOBILE ~RMY SURGIC~L HOSPIT~LS (M~SH)    COMB~T SUPPORT HOSPIT~L

      (CSH)  EV~CU~TION HOSPIT~LS (EV~C)   ~ND MEDIC~L TECHNIC~L
      INTELLIGENCE TE~MS~
           B. (U)~~~  CORPS/DIVISION SURGEONS ~RE RESPONSIBLE FOR


      P~GE O~ RHIP~~~2597 0 E D
      COORDIN~TING DELIVERY OF S~MPLES THROUGH MILIT~RY INTELLIGENCE
      CH~NNELS TO THE CORPS G2 (TECHNIC~L INTELLIGENCE SECTION)
      DOCUMENTING S~MPLE TR~NSFERS ON DD FORM 1911, M~TERIEL COURIER
      RECEIPT.
           C. (U~~    BIOMEDIC~L S~MPLES FROM SUSPECTED CB EXPOSURES INCLUDE
      URINE (2C~ - 5C~ CC X :) BLOOD OR SERUM (5CC X .3)  CSF (2CC X 3)  ~ND
      SPUTUM (ONLY IF ~CUTELY ILL, X3).   TISSUE OBT~INED PRE OR POST MORTEM
      SHOULD BE 4T LE~ST 30 8R~MS IN TRIPLIC~TE.    MEDI~STIN~L LYMPH NODES
      ~~~RE ESPECI~LLY IMPORT~NT IF ~V~IL~BLE.  ROUTINE DI~GNOSTIC
      MICROBIOLOGY   (GR~M ST~IN; CULTURE WHERE ~V~IL~BLE) M~Y GIVE RE~DY
      ~NSWERS, ESPECI~LLY IN F~T~L C~SES. PERTINENT CLINIC~L D~T~ IS TO
      ~~~~~~~~~ THE SPECIMEN ON ~ US~MRIID FORM 97 (CHEMIC~L/BIOLOSIC~L
      W~RF~RE SPECIMEN DOCUMENT~TION, MEDIC~L RECORDS).     SEE REFERENCE B,


   `- PRIORITY               *            C E     ~ E T           *

Document Page: First | Prev | Next | All | Image | This Release | Search